Pfizer 00013264681 McKesson Medical-Surgical
Pfizer 00013264681 McKesson Medical-Surgical
Certain brands of somatropin contain an ingredient that can cause serious side effects or death in very young infants or premature babies. Serious breathing problems may occur in patients with Prader-Willi syndrome who use Genotropin. If you have Prader-Willi syndrome, call your doctor promptly if you develop signs of lung or breathing problems such as shortness of breath, coughing, or new or increased snoring. Genotropin is a form of human growth hormone important for the growth of bones and muscles.
- Certain medications may interact with Genotropin (12mg/ml) 36IU injection and cause undesirable side effects.
- Before starting to use this product you need to activate it properly first.
- All 12 patients had predisposing factors, e.g., elevated glycated hemoglobin levels and/or marked obesity, prior to receiving GENOTROPIN.
- Inform your physician about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment.
- Patients and caregivers who will administer GENOTROPIN should receive appropriate training and instruction on the proper use of GENOTROPIN from the physician or other suitably qualified health care professional.
Pharmacologic glucocorticoid therapy and supraphysiologic glucocorticoid treatment may attenuate the growth promoting effects of somatropin in children. Therefore, glucocorticoid replacement dosing should be carefully adjusted in children receiving concomitant somatropin and glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. GENOTROPIN is indicated for the treatment of pediatric patients who have growth failure due to Prader-Willi syndrome (PWS).
What should I avoid while using Genotropin?
Since there are too many fake pfizer genotropins lately, we ask our valued customers to be careful about this issue. Consult doctors online from the comfort of your home for free. Chat privately with our registered medical specialists to connect steroids where to buy directly with verified doctors. Book any lab tests and preventive health packages from certified labs and get tested from the comfort of your home. Enjoy free home sample collection, view reports online and consult a doctor online for free.
Clinical Pharmacology
Our mission is to support, not replace, the doctor-patient relationship. Genotropin (12mg/ml) 36IU injection is administered as a subcutaneous injection, which is injected just under the skin. The injection site can vary, but common areas include the thigh, buttocks, or abdomen. A physician should provide specific dosage and administration instructions. Genotropin (12mg/ml) 36IU injection will be given under the skin (subcutaneously).
Drug Interactions
Intracranial tumors, in particular meningiomas, were the most common of these second neoplasms. In adults, it is unknown whether there is any relationship between somatropin replacement therapy and CNS tumor recurrence [see Contraindications (4)]. Monitor all patients with a history of GHD secondary to an intracranial neoplasm routinely while on somatropin therapy for progression or recurrence of the tumor. Genotropin is a synthetic human growth hormone (hGH) used in clinical practice. It’s prescribed for children and adults with growth hormone deficiencies, short stature, or conditions like Turner syndrome. Dosage and administration are determined by healthcare professionals to address specific medical needs.
Patients with Turner syndrome should be evaluated carefully for otitis media and other ear disorders since these patients have an increased risk of ear and hearing disorders. Somatropin treatment may increase the occurrence of otitis media in patients with Turner syndrome. In addition, patients with Turner syndrome should be monitored closely for cardiovascular disorders (e.g., stroke, aortic aneurysm/dissection, hypertension) as these patients are also at risk for these conditions. Serious systemic hypersensitivity reactions including anaphylactic reactions and angioedema have been reported with post-marketing use of somatropin products. Patients and caregivers should be informed that such reactions are possible and that prompt medical attention should be sought if an allergic reaction occurs [see Contraindications (4)].
Your pen can still be used correctly, but the dose size will not be displayed. If you have any questions about your dose or your treatment with GENOTROPIN, call your healthcare provider right away. The mean clearance of subcutaneously administered GENOTROPIN in 16 GHD adult patients was 0.3 (± 0.11) L/hrs/kg.